AZD4547 10 mg | 99.56%
TargetMol
AZD4547, a new-type specific FGFR inhibitor, targets for FGFR1/2/3 (IC50: 0.2/2.5/1.8 nM in cell-free assays).
More Information Supplier PageAZD4547
Search Results
AZD4547 100 mg | 99.56%
TargetMol
AZD4547, a new-type specific FGFR inhibitor, targets for FGFR1/2/3 (IC50: 0.2/2.5/1.8 nM in cell-free assays).
More Information Supplier PageAZD4547
Necrostatin-1 50 mg | 99.74%
TargetMol
Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis (EC50: 490 nM in Jurkat cells).
More Information Supplier PageNecrostatin-1
Necrostatin-1 25 mg | 99.74%
TargetMol
Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis (EC50: 490 nM in Jurkat cells).
More Information Supplier PageNecrostatin-1
Necrostatin-1 10 mg | 99.74%
TargetMol
Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis (EC50: 490 nM in Jurkat cells).
More Information Supplier PageNecrostatin-1
U0126-EtOH 10 mg | 98.65%
TargetMol
U0126-EtOH is a non-ATP competitive specific inhibitor of MEK1/2 (IC50: 0.07/0.06 μM).
More Information Supplier PageU0126-EtOH
U0126-EtOH 100 mg | 98.65%
TargetMol
U0126-EtOH is a non-ATP competitive specific inhibitor of MEK1/2 (IC50: 0.07/0.06 μM).
More Information Supplier PageU0126-EtOH
Volasertib 5 mg | 98.04%
TargetMol
Volasertib (BI-6727) is a potent inhibitor of PLK1 (IC50: 0.87 nM), inducing mitotic arrest and apoptosis. It also inhibits PLK2/PLK3 (IC50s: 5/56 nM).
More Information Supplier PageVolasertib
Volasertib 50 mg | 98.04%
TargetMol
Volasertib (BI-6727) is a potent inhibitor of PLK1 (IC50: 0.87 nM), inducing mitotic arrest and apoptosis. It also inhibits PLK2/PLK3 (IC50s: 5/56 nM).
More Information Supplier PageVolasertib
Volasertib 2 mg | 98.04%
TargetMol
Volasertib (BI-6727) is a potent inhibitor of PLK1 (IC50: 0.87 nM), inducing mitotic arrest and apoptosis. It also inhibits PLK2/PLK3 (IC50s: 5/56 nM).
More Information Supplier PageVolasertib